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Veterinary Immunology and Immunopathology 116 (2007) 199–214AbstractWe previously showed that an intradermal (i.d.) FaeG DNA prime (2)-oral F4 protein boost immunization induces a systemic
response and weakly primes a mucosal IgG response in pigs, especially when plasmid vectors encoding the A and B subunit of theE.
coli thermo-labile enterotoxin (LT) are added to the DNA vaccine. In the present study, we evaluated whether addition of 1a,25-
dihydroxyvitamin D3 (vitD3) to the DNA vaccine could further enhance this mucosal priming and/or modulate the antibody
response towards IgA. To further clarify priming of systemic and mucosal responses by the i.d. DNA vaccination, we firstly
compared the localization of the F4-specific antibody response in pigs that were orally boosted with F4 to that in pigs that received a
third i.d. DNA immunization and secondly evaluated cytokine mRNA expression profiles after i.d. DNAvaccination. The i.d. DNA
prime (2)-oral F4 boost immunization as well as the 3 i.d. DNA vaccinations induced mainly a systemic response, with a higher
response observed following the heterologous protocol. Co-administration of vitD3, and especially of the LT vectors, enhanced this
response. Furthermore, only the heterologous immunization resulted in a weak mucosal priming, which appeared to require the
presence of the LT vectors or vitD3 as adjuvants. In addition, the LT vectors strongly enhanced the FaeG-specific lymphocyte
proliferation and this was accompanied by the absence of a clear IL-10 response. However, despite two DNA immunizations in the
presence of these adjuvants and an oral F4 boost, we failed to demonstrate the secretory IgA response needed to be protective
against enterotoxigenic E. coli.
# 2007 Elsevier B.V. All rights reserved.
Keywords: Pig; DNA vaccination; Mucosal IgG1. Introduction
Enterotoxigenic E. coli (ETEC) that express F4
(K88) fimbriae are an important cause of diarrhea in
recently weaned piglets. The F4 fimbriae are long
proteinaceous appendages mainly composed of several
hundreds identical FaeG subunits. They enable the* Corresponding author. Tel.: +32 9264 73 84; fax: +32 9264 74 96.
E-mail address: Vesna.Melkebeek@UGent.be (V. Melkebeek).
0165-2427/$ – see front matter # 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetimm.2007.01.021bacteria to adhere to F4-specific receptors (F4R) on the
intestinal epithelium and subsequently to colonize the
small intestine (Nagy et al., 1985). Presence of the F4R
is genetically determined and F4R negative (F4R) pigs
are resistant to an F4 positive (F4+) ETEC infection
(Rutter et al., 1975). It was previously shown that oral
immunization of F4R+ weaned pigs with F4 fimbriae
resulted in an antigen-specific secretory IgA (sIgA)
response at the intestinal mucosa, protecting these pigs
against a subsequent F4+ ETEC challenge (Van den
Broeck et al., 1999a). However, to prevent post-weaning
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response should already be primed during the suckling
period, often in the presence of F4-specific maternal
antibodies. These lactogenic antibodies will hamper the
use of F4 as a vaccine. Several studies have shown that
DNAvaccines, in contrast to conventional vaccines, can
successfully prime immune responses in the presence of
maternal antibodies (Hassett et al., 1997; Fischer et al.,
2003; Van Loock et al., 2004). Therefore, we
hypothesized that priming with an FaeG DNA vaccine
during the suckling period combined with an oral F4
protein boost immediately after weaning could be an
interesting approach. However, in a previous study a
parenteral DNA prime-oral F4 boost induced a good
systemic response, but was weak in priming mucosal
immunity, failing to completely prevent F4+ E. coli
colonization. Furthermore, addition of plasmid vectors
encoding the LTA and LTB subunits to the FaeG DNA
vaccine enhanced the IgG response, but did not result in
the sIgA response that is desired to completely prevent
an F4+ ETEC infection. Nevertheless, a significant
reduction was obtained in the amount of F4+ ETEC
excreted as well as in the duration of faecal F4+ ETEC
excretion (Melkebeek et al., 2007). These data suggest
that the systemic DNA immunization is weak in
priming mucosal responses. Previous studies showed
that a systemic immunization could induce an intestinal
mucosal IgA response in mice (Enioutina et al., 1999,
2000) and in pigs (Van der Stede et al., 2001, 2004) if
1a,25-dihydroxyvitamin D3 (vitD3) was used as
adjuvant.
Therefore, we examined in the present study whether
addition of vitD3 could enhance the mucosal priming by
the FaeG DNA vaccination and/or whether it could
modulate the antibody response towards IgA in the i.d.
DNA prime-oral F4 boost immunization. Furthermore,
to gain insight in the way systemic and mucosal
responses are primed by the i.d. DNA vaccination, we
compared the localization of the F4-specific antibody
response in pigs that were orally boosted with F4 to that
in pigs that were reimmunized i.d. with DNA and we
evaluated cytokine mRNA expression profiles in the
local draining lymph nodes after the i.d. DNA priming.
2. Materials and methods
2.1. Animals
Forty-nine conventionally bred pigs (Belgian Land-
race x Pie´train), seronegative for antibodies against F4
as determined by ELISA, were weaned at the age of
4 weeks. Subsequently, they were housed in isolationunits. From 1 day before weaning, all animals were
orally treated with colistine (150,000 U/kg body
weight; Colivet, Prodivet Pharmaceuticals, Eynatten,
Belgium) during 5 successive days to prevent E. coli
infections during the weaning period.
2.2. Isolation of F4 fimbriae
F4 fimbriae were isolated from the ETEC strains
GIS26, serotype 0149:K91:F4ac, LT+STa+STb+, and
IMM01, serotype 0147:F4ac, LT+STb+ as described by
Van den Broeck et al. (1999a). The protein concentra-
tions of the fimbrial solutions were determined by the
bicinchoninic acid reaction with bovine serum albumin
as a standard (ICN Biomedicals, Belgium) and the
purity was assessed using a Coomassie stained 15%
SDS-PAGE and the Image Master 1D prime software
(Amersham Pharmacia Biotech, Belgium). GIS26 F4
fimbriae were used for the oral immunization of pigs.
The IMM01 strain carries F4 fimbriae with an FaeG
sequence identical to the GIS26 strain, but fimbriae
isolated from this strain have a higher purity, containing
no flagellin (Verdonck et al., 2004). Therefore, IMM01
fimbriae were used for the FaeG-specific ELISA and
ELIspot assays and, after sterilization by filtration
through a 0.2 mm filter, in an FaeG-specific lymphocyte
proliferation assay.
2.3. Plasmids and 1a,25(OH)2D3
The pcDNA3-rpGM-CSF plasmid consists of the
cDNA encoding the porcine GM-CSF cloned in the
pcDNA3.1zeo expression vector.
The pWRGFaeGopt vaccine was constructed as
previously described (Melkebeek et al., 2007). This
construct consists of a codon optimized faeG cloned
into the pWRG7079 vector behind a tPA signal
sequence, allowing the extracellular secretion of the
encoded FaeG. The pJV2004 and pJV2005 plasmids
consist of the pWRG7054 vector encoding the A and B
subunit of the thermolabile enterotoxin of E. coli (LT),
respectively, behind a tPA signal sequence to allow their
extracellular secretion (Arrington et al., 2002). All
plasmids were propagated in E. coli DH5a and large-
scale purification of the plasmids was conducted
by Qiagen Endofree plasmid kits (Qiagen GmbH,
Germany). After determining purity and concentration
by measuring the O.D. at 260 and 280 nm, the plasmids
were stored at 20 8C.
1a,25(OH)2D3 (vitD3) (Sigma), was dissolved in
absolute ethanol at a concentration of 200 mg/ml and
stored at 4 8C.
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2.4.1. Experiment 1
A first experiment was performed to confirm the
induction of an F4-specific systemic immune response
by i.d. immunization with pWRGFaeGopt or
pWRGFaeGopt in combination with the LT vectors
as well as the priming of an F4-specific intestinal
mucosal IgG response by i.d. immunization with these
vectors followed by an oral F4 boost as seen in a
previous study (Melkebeek et al., 2007). Furthermore,
we wanted to evaluate if the immunomodulating
adjuvant vitD3 could enhance the mucosal priming
by the FaeG DNAvaccine and/or modulate the induced
response towards an IgA response.
Hereto, 23 pigs were used (Table 1). One week post-
weaning, they were divided into 4 groups and were all
injected intradermally (i.d.) at the left site of the neck
with 250 mg of pcDNA3-rpGM-CSF. Seven and 28 days
later (days 0 and 21 post primary immunization (ppi)),
the pigs were i.d. immunized at this site (at the pcDNA3-
rpGM-CSF injection site) with 500 mg of pWRGFae-
Gopt (n = 7, pWRGFaeGopt group), pWRGFaeGopt
supplemented with 100 mg pJV2004 and 100 mg
pJV2005 (collectively referred to as the LT vectors)
(n = 7, pWRGFaeGopt + LT group), pWRGFae-
Gopt supplemented with 5 mg of 1a,25(OH)2D3
(n = 5, pWRGFaeGopt + vitD3 group) or the empty
pWRG7079 vector (n = 4, pWRG7079 group).At day 42
ppi, 4 pigs of both the pWRGFaeGopt and the
pWRGFaeGopt + LT group and 2 pigs of both the
pWRGFaeGopt + vitD3 and the pWRG7079 group
received an identical i.d. booster immunization, whereas
the remaining pigs (3 pigs of each immunized group and
2pigs of the pWRG7079group)were orally boostedwith
1 mg F4 fimbriae diluted in 10 ml PBS during 3
successive days (days 42, 43 and 44 ppi, respectively).Table 1
Experimental design of experiment 1
Group Day -7 DNA vaccine
(days 0 and
21 ppi)
pWRG7079 (control) pcDNA3-rpGM-CSF pWRG7079
pWRGFaeGopt (FaeG) pcDNA3-rpGM-CSF pWRGFaeGopt
pWRGFaeGopt + LT (LT) pcDNA3-rpGM-CSF pWRGFaeGopt
pWRGFaeGopt + vitD3 (vitD3) pcDNA3-rpGM-CSF pWRGFaeGoptThe animals were deprived of food and water from 3 h
before till 2 h after the oral immunization. The F4-
specific humoral immune responsewas analyzed weekly
by determining the F4-specific IgG, IgA and IgM titer in
the serum of all pigs starting from day 7 till day 48 ppi. In
order to localize and quantify the antibody response, the
pigs were euthanized 6 or 7 days after the third
immunization (day 48 or 49 ppi, respectively) for
enumeration of the F4-specific IgG, IgA and IgM
antibody-secreting cells (ASC) in the lymph node
draining the DNA vaccination site (cervical superficial
dorsal lymph node (Cerv LN)), the mesenteric LN (Mes
LN), the ileal and jejunal Peyer’s patches (IPP and JPP),
the jejunal lamina propria (LP) and the spleen. To
evaluate the induction of an F4-specific cellular
response, an F4-specific lymphocyte proliferation assay
was performed on spleen monomorphonuclear cells
(MC). Since the F4 receptor (F4R) is essential for
inducing an intestinal IgA response, the presence of the
F4R was determined on small intestinal villi as earlier
described.
2.4.2. Experiment 2
A second experiment was performed to examine the
induction of cellular immune responses (FaeG-specific
lymphocyte proliferation and cytokine mRNA expres-
sion) in the local draining lymph node (Cerv LN)
following priming with the FaeG DNA vaccine and to
evaluate the influence of the intradermal LT vectors or
vitD3 on these cellular responses. Hereto, 26 pigs were
used (Table 2). One week after weaning, 6 pigs were i.d.
injected in the neck with sterile PBS (PBS group) and
the other pigs with 250 mg of pcDNA3-rpGM-CSF.
Seven and 28 days later (days 0 and 21 ppi), the pigs
were i.d. injected at the same site with PBS (pigs from
the PBS group) or 500 mg of pWRGFaeGopt (n = 5,
pWRGFaeGopt group), pWRGFaeGopt supplementedThird
immunization
(day 42 ppi)
Total
number
of pigs
F4R+
pigs
F4R
pigs
pWRG7079 2 1 1
Oral F4 2 1 1
pWRGFaeGopt 4 3 1
Oral F4 3 1 2
+ LT pWRGFaeGopt + LT 4 3 1
Oral F4 3 1 2
+ vitD3 pWRGFaeGopt + vitD3 2 1 1
Oral F4 3 2 1
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Table 2
Experimental design of experiment 2
Group Total number
of pigs
Day -7 Days 0 and 21 ppi Number of pigs
at 24 h psi
Number of pigs
at 48 h psi
PBS 6 PBS PBS 3 3
pWRG7079 4 pcDNA3-rpGM-CSF pWRG7079 2 2
pWRGFaeGopt 5 pcDNA3-rpGM-CSF pWRGFaeGopt 3 2
pWRGFaeGopt + LT 6 pcDNA3-rpGM-CSF pWRGFaeGopt + LT 2 4
pWRGFaeGopt + vitD3 5 pcDNA3-rpGM-CSF pWRGFaeGopt + vitD3 2 3with 100 mg of each LT vector (n = 6, pWRGFae-
Gopt + LT group), pWRGFaeGopt supplemented with
5 mg of 1a,25(OH)2D3 (n = 5, pWRGFaeGopt + vitD3
group) or pWRG7079 (n = 4, pWRG7079 group). The
pigs were euthanized 24 or 48 h after the second
immunization (psi) as shown in Table 2 and for each pig
the cervical superficial dorsal LN was collected at the
left site (Cerv LN) and the right site (control Cerv LN)
of the neck to analyze cytokine expression profiles.
Cerv LN MC isolated at 48 h psi were also used in an
F4-specific lymphocyte proliferation assay.
In both experiments, plasmids were diluted in 1 ml
sterile PBS and both the i.d. injection with pcDNA3-
rpGM-CSF as the i.d. immunizations were performed
by multiple injections. Euthanasia of all pigs was
performed by intravenous injection of pentobarbital
(24 mg/kg; Nembutal, Sanofi Sante´ Animale, Brussels,
Belgium) followed by exsanguinations.
2.5. Spleen, Cerv LN, Mes LN, JPP, IPP and LP
MC
MCwere isolated from the spleen, Cerv LN, Mes LN
(jejunal and ileal), JPP, IPP and LP as described by
Verdonck et al. (2002) and finally resuspended in
leukocyte medium [RPMI-1640 (GIBCO BRL) sup-
plemented with penicillin (100 IU/ml) (GIBCO BRL),
streptomycin (100 mg/ml) (GIBCO BRL), kanamycin
(100 mg/ml) (GIBCO BRL), L-glutamin (200 mM)
(GIBCO BRL), sodiumpyruvate (100mM) (GIBCO
BRL), non-essential aminoacids (100 mM) (GIBCO
BRL), 2-mercaptoethanol (5  105 M) (GIBCO BRL)
and either 5% serum of a colostrum-deprived pig for the
lymphocyte proliferation assay or 10% FCS for the
ELISPOT assay]. Cerv LN MC were also resuspended
in TRIzol Reagent (Invitrogen, Merelbeke, Belgium)
(Cerv LN) to analyze cytokine mRNA expression.
2.6. RNA extraction and RT-PCR
RNA was extracted from 107 MC/sample using
TRIzol Reagent following the manufacturer’s protocol.Reverse transcription was performed as described by
Verfaillie et al. (2005). The oligonucleotide primers
described by Verfaillie et al. (2005) were used for the
detection of the porcine cytokines IL-2, IL-4, IL-6, IL-
10, TGF-b, IFN-g, TNF-a and of cyclophilin cDNA.
Oligonucleotide primers used for the detection of b-
actin and GAPDH cDNA were designed from the
published nucleic acid sequences available from the
GenBank/EMBL databases using the primer3 software
(http://frodo.wi.mit.edu/cgibin/primer3/pri-
mer3_www.cgi) (Table 3).
Real-time PCR reactions were carried with the
LightCycler and the LightCycler-faststart DNA Master
SYBR Green I kit (Roche, Mannheim, Germany). The
reactions for IL-2, IL-4, IL-6, IL-10, TGF-b, IFN-g,
TNF-a and of cyclophilin were performed as described
by Verfaillie et al. (2005). For b-actin and GAPDH, the
reaction mixture was made following the manufac-
turer’s protocol using 3 mM MgCl2. After heating the
samples at 958C for 10 min, the temperature cycling
consisted of denaturation at 948 for 15 s, annealing at
538C (GAPDH) or 60 8C (b-actin) for 5 s, and extension
at 728C for 14 s. For b-actin 35 cycles and for GAPDH
40 cycles were performed. Fluorescence acquisition
was measured at 85 8C in single mode. Melting curve
analysis was done at 65-98 8C with continuous
fluorescence acquisition. As an additional control of
specificity, PCR products were subjected to agarose gel
electrophoresis. Quantification occurred using external
standards of cDNA and the copy number of each sample
transcript was determined with the aid of the Light-
Cycler software. Cyclophilin, GAPDH and b-actin
were used as constitutively expressed reference genes
and a normalization factor (NF) was calculated as the
geometric mean of the copy numbers of these 3 genes to
determine the uniformity of the reverse transcription
and as a reference for quantification of cytokine mRNA.
The relative amounts of cytokine-expression were
calculated as a ratio of the copy number of the target
cytokine over the NF and results are presented as the
ratio of the relative amount of the target cytokine in the
immunized Cerv LN over the relative amount of the
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Table 3
Oligonucleotide primers and fragment length of PCR products for different porcine cytokines
Cytokine Primers (50-30) Length PCR fragment Genbank accession number
IL-1a (S) TGCCAGCTATGAGCCACTTCC 336 X52731
(AS) TGACGGGTCTCGAATGATGCT
IL-2 (S) GATTTACAGTTGCTTTTGAAG 338 X56750
(AS) GTTGAGTAGATGCTTTGACA
IL-4 (S) TACCAGCAACTTCGTCCA 311 F68330
(AS) ATCGTCTTTAGCCTTTCCAA
IL-6 (S) ATGAGAATCACCACCGGTCTTG 310 M86722
(AS) TGCCCCAGCTACATTATCCGA
IL-10 (S) CCATGCCCAGCTCAGCACTG 295 L20001
(AS) CCCATCACTCTCTGCCTTCGG
IFN-g (S) ATGTACCTAATGGTGGACCTC 360 X53085
(AS) CTCTCTGGCCTTGGAACATAG
TGF-b (S) GACCCGCAGAGAGGCTATAG 399 Y00111
(AS) GAGCCAGGACCTTGCTGTAC
TNF-a (S) CAAGGACTCAGATCATCGTCTCA 100 X54859
(AS) CATACCCACTCTGCCATTGGA
Cyclophilin (S) TAACCCCACCGTCTTCTT 368 F14571
(AS) TGCCATCCAACCACTCAG
b-Actin (S) ACGTGGACATCAGGAAGGAC 210 U07786
(AS) ACATCTGCTGGAAGGTGGAC
GAPDH (S) GGGCATGAACCATGAGAAGT 230 AF017079
(AS) AAGCAGGGATGATGTTCTGG
(S): Sense; (AS): Antisense.target cytokine in the control Cerv LN = (copy number
of target cytokine in the Cerv LN/NF in the Cerv LN)/
(copy number of target cytokine in the control Cerv LN/
NF in the control Cerv LN).
2.7. FaeG-specific lymphocyte proliferation assay
To determine the FaeG-specific lymphocyte pro-
liferation, a proliferation assay as described by Van
der Stede et al. (2003) was performed on spleen or
Cerv LN MC by adding F4 fimbriae (final concentra-
tion of 15 mg/ml), medium (negative control) or
concanavalin A (ConA, final concentration of 10 mg/
ml, positive control) to the wells of a 96-well plate
(Cellstar, Greiner bio-one, Wemmel, Belgium) con-
taining 5  105 cells/well (final volume of 200 ml).
After 72 h at 37 8C in 5% CO2, cells were pulse-
labelled with 3H-thymidine (1mCi/well) (Amersham
ICN, Bucks, UK) and 18 h later, they were harvested
onto glass fibre filters. The radioactivity incorporated
into the DNA was measured with a b-scintillation
counter (Perkin-Elmer, Life Science, Brussels,
Belgium).2.8. ELISA for FaeG-specific serum IgG, IgA and
IgM antibodies
FaeG-specific titers were determined by an indirect
ELISA on serum sampled as described by Van den
Broeck et al. (1999b). Hereto, the wells of a 96-well
microtitre plate (NUNC, Polysorb Immuno Plates,
Roskilde, Denmark) were coated with IMM01 F4
fimbriae at a concentration of 5 mg/ml in PBS. After 2 h
incubation at 37 8C, the remaining binding sites were
blocked overnight at 48C with PBS supplemented with
0.2% Tween1 80 (Merck Eurolab, Leuven, Belgium).
Subsequently, the sera were added for 1 h at 378C in
series of two-fold dilutions in ELISA dilution buffer
(PBS, pH 7.4 + 0.2% Tween1 20 + 3% BSA), starting
at a dilution of 1/10. Then, optimal dilutions of anti-
swine IgM-, IgA- or IgG-specific MAb (28.4.1, 27.8.1
and 23.3.1b, respectively, Van Zaane and Hulst, 1987)
in ELISA dilution buffer were added to the wells for 1 h
at 37 8C. Thereafter, rabbit anti-mouse HRP-conjugated
serum (Dako, Denmark) optimally diluted in ELISA
dilution buffer and supplemented with 2% pig serum
was added for 1 h at 37 8C. Finally, ABTS (Roche
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added and after 30 min incubation at 378C, the optical
density was measured spectrophotometrically at
405 nm (O.D.405). Between each incubation step, the
plates were washed three times with ELISA washing
buffer (PBS, pH 7.4 + 2% Tween 20). Cut-off values
were calculated as the mean O.D.405 of all sera (dilution
1/10) on day 0 ppi increased with three times the
standard deviation and were 0.16, 0.23 and 0.63 for IgA,
IgG and IgM, respectively. The antibody titer was the
inverse of the highest dilution which still had an O.D.405
higher than the calculated cut-off values.
2.9. Elispot assay for FaeG-specific IgG, IgA and
IgM ASC
F4-coated plates were prepared as described for the
ELISA. Thereafter, MC suspensions at a concentration
of 107cells/ml were added (100 ml/well) and plates were
incubated for 14 h at 37 8C in a humidified 5% CO2
atmosphere. Subsequently, the cells were removed by
six washes with ELISAwashing buffer whereafter wells
were sequentially incubated for 1 h at 37 8C with the
anti-swine IgM-, IgA- or IgG-specific MAb and with a
rabbit anti-mouse HRP-conjugated serum. Between
these steps, the plates were washed 3 times with ELISA
washing buffer. Subsequently, a substrate solution,
consisting of 4 volumes of 3-amino-9-ethylcarbazole
(AEC) (Sigma) working solution (0.67 ml AEC stock
solution (0.4% in dimethylformamide) in 10 ml Na
acetate (0.1 M, pH 5.2) + 10 ml 30% H2O2) and 1
volume of 3% low-melting-point agarose (BIOzym,
Landgraaf, The Netherlands) was added. After over-
night incubation in the dark at room temperature, spots
were counted with an inverted microscope. For each
MC suspension, spots in five wells (106 MC/well) were
counted to obtain the number of isotype-specific ASC/
5  106 MC. Results are presented as the mean number
of ASC per 5  106 MC  S.E.M.
2.10. Statistical analysis
Statistical analysis was done using SPSS 12.0 for
Windows. Analysis of differences between the groups in
log2 serum antibody titers was done using General
Linear Model (Repeated Measures Analysis of Var-
iance) using the Bonferoni adjustment for multiple
comparisons. Differences between groups in lympho-
cyte proliferation and in relative increase in cytokine
expression at the immunization site were tested for
statistical significance with the Kruskal–Wallis Test.
P  0.05 was considered as statistically significant.3. Results
3.1. Experiment 1: FaeG-specific antibody
responses following DNA vaccination
3.1.1. F4R characterization of the pigs
As shown in Table 1, the in vitro villous adhesion
assay demonstrated that 6 of the 11 pigs that were orally
boosted with F4 and 4 of the 12 pigs that were i.d.
boosted with DNA lacked the F4R.
3.1.2. FaeG-specific serum antibody response
following 2 intradermal DNA vaccinations
Pigs were immunized i.d. with DNA at days 0 and 21
ppi. Since pre-injection with pcDNA3-rpGM-CSF
enhances both humoral and cellular responses in pigs
(Melkebeek et al., 2006), all pigs received an i.d.
injection with this plasmid seven days before the first
immunization (Table 1).
FaeG-specific serum IgG was already observed after
1 immunization with pWRGFaeGopt and addition of LT
enhanced this IgG response (Fig. 1). VitD3 was a less
powerfull adjuvant, enhancing the IgG response to a
lesser extend. Control animals vaccinated with
pWRG7079, did not show an IgG response. Conse-
quently, the mean FaeG-specific IgG titer was
significantly higher in the pWRGFaeGopt + LT than
in the pWRGFaeGopt and the pWRG7079 group and in
the pWRGFaeGopt + vitD3 group than in the
pWRG7079 group from 7 days after the second
immunization (day 28 ppi) till the third immunization
(day 42 ppi).
Levels of FaeG-specific IgA and IgM antibodies
remained very low (mean titers  18 in all groups).
3.1.3. FaeG-specific responses following an oral F4
boost or a third i.d. DNA vaccination
To determine if the i.d. DNA vaccination induced an
FaeG-specific intestinal mucosal antibody response or
primed the gut-associated lymphoid tissues (GALT),
pigs were either immunized a third time with DNA (day
42 ppi) or obtained an oral boost with 1 mg F4 fimbriae
during 3 successive days (days 42, 43 and 44 ppi)
(Table 1). Mucosal and systemic responses were
analyzed 6 or 7 days later.
3.1.3.1. The FaeG-specific serum antibody respon-
se. Both the oral F4 boost and the i.d. DNAvaccination
further enhanced the FaeG-specific serum IgG titers in
all the FaeG DNA primed groups, irrespective of the
F4R status of the animals, whereas the pWRG7079
animals remained negative (Fig. 2).
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Fig. 1. FaeG-specific serum IgG, IgA and IgM titers following 2 i.d. immunizations with pWRGFaeGopt (n = 7), pWRGFaeGopt + LT (n = 7),
pWRGFaeGopt + vitD3 (n = 5) or pWRG7079 (controls, n = 4) (days 0 and 21 ppi, black arrows). Significant differences (P < 0.05) between the
pWRGFaeGopt + LT group and the pWRGFaeGopt and the control group and between the pWRGFaeGopt + vitD3 group and the control group are
indicated with the symbol (*). Results are presented as means  S.E.M.None of the groups showed increased FaeG-specific
serum IgA or IgM titers following the DNA or the F4
boost (data not shown).
3.1.3.2. Localization of the FaeG-specific antibody
response. FaeG-specific ASC were mainly detected in
the Cerv LN (Fig. 3) and to a lesser extend in the spleen
(Fig. 4). In the control group, no FaeG-specific ASCwere identified in the Cerv LN, whereas a background
of FaeG-specific IgM was identified in the spleen after
the third injection with pWRG7079 (negative controls,
16–21 ASC/5  106 MC) as well as after the oral F4
immunization (18–44 ASC/5  106 MC).
In all FaeG DNA vaccinated groups, the third i.d.
DNA vaccination induced mainly FaeG-specific IgG
(7–305 ASC/5  106 MC) and to a lesser extend IgM
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Fig. 2. Mean FaeG-specific serum IgG titer at the day of the third
immunization (day 42 ppi) and 6 days later (day 48 ppi). Pigs were
immunized as shown in Table 1.ASC (3–92 ASC/5  106 MC) in the Cerv LN, whereas
mainly IgM (15-209 ASC/  106 MC) and to a lesser
extend IgGASC (0–39 ASC/5  106MC) were induced
in the spleen. Moreover, the numbers of FaeG-specific
ASC in the Cerv LN and the spleen were comparable for
the three FaeG DNA vaccinated groups. For FaeG-
specific IgA, lower numbers of ASC could only be
detected in the Cerv LN of most animals in all
vaccinated groups (0–29 ASC/5106 MC).
In the pWRGFaeGopt group, the oral F4 boost
induced comparable FaeG-specific antibody responses
in the Cerv LN and the spleen as the third i.d. DNA
immunization. Indeed, similar mean numbers of FaeG-
specific IgG ASC were detected in the Cerv LN of
orally and i.d. boosted pigs (122 and 131 ASC/5  106
MC, respectively). In addition, also mainly FaeG-
specific IgMASCwere found in the spleen of the orally
boosted pigs of this group. In the pWRGFaeGopt + LT
and the pWRGFaeGopt + vitD3 group however, the
oral F4 seemed to ‘‘boost’’ the systemic antibody
response stronger than the third i.d. DNA immunization
did. Indeed, in the Cerv LN of these groups, larger
numbers of FaeG-specific IgG ASC were detected in
the orally boosted pigs (143–696 and 69–854 ASC/
5  106 MC for the pWRGFaeGopt + LT and the
pWRGFaeGopt + vitD3 group, respectively) than in
pigs that were immunized three times with DNA.
Moreover, the FaeG-specific ASC in the spleen of the
orally boosted pigs were mainly IgG (39–96 and 28–
53 ASC/5  106 MC for the pWRGFaeGopt + LT and
the pWRGFaeGopt + vitD3 group, respectively),
whereas it was meanly IgM following the third DNA
immunization. After the oral F4 boost, FaeG-specific
IgA ASC could not be detected in the Cerv LN.
However, few FaeG-specific IgA ASC could be
detected in the spleen of all three FaeG DNA primed
groups (0–4 ASC/5  106 MC, respectively).
In the GALT (Fig. 5), low numbers of IgA and IgM
ASC could be detected in the orally boosted pigs of thepWRG7079 control group (up to 3 and 12 ASC/5  106
MC, respectively), whereas higher numbers were seen
in some FaeG DNA primed orally boosted pigs. Indeed,
high numbers of IgM ASC could be detected in the IPP,
JPP and Mes LN of one F4R-positive pig primed with
pWRGFaeGopt + vitD3 (10–173 ASC/5  106 MC).
An improved intestinal IgM response by DNA priming
could also be observed in the LP of two F4R-negative
pigs of the pWRGFaeGopt + LT group (21 and 35 ASC/
5  106MC), and in the IPP and JPP of one of these pigs
and of one pig of the pWRGFaeGopt group (up to 31
and 28 ASC/5  106 MC, respectively). For these pigs,
the numbers of IgA ASC were between 0 and 7 ASC/
5  106 MC in the IPP, JPP and Mes LN and up to
25 ASC/5  106 MC in the LP.
The oral F4 boost seemed to weakly induce an IgG
response in the GALTof DNA primed pigs. Indeed, IgG
ASC could be detected in the GALTof some of the FaeG
DNA primed pigs, whereas none of the control pigs
showed IgG ASC in their GALT (Fig. 5). However, only
in the F4R-positive pig of the pWRGFaeGopt + vitD3
group with high numbers of intestinal IgM ASC, the
numbers of FaeG-specific IgG ASC were consistently
high in all examined GALT (22–346 ASC/5  106MC).
In all other DNA primed pigs which received an oral F4
boost, except for one pig of the pWRGFaeGopt group,
the numbers of IgG ASC were between 1 and 14 in the
Mes LN. This was irrespective of the F4R status of the
animals and occurred in higher numbers in both
adjuvanted groups. In the other GALT, FaeG-specific
IgG ASC could be detected in low numbers (1–4 ASC/
5  106 MC) (Fig. 5). This was mainly seen in the
pWRGFaeGopt + LT group and more sporadically in
both other DNA primed groups.
After three i.d. DNA immunizations, none of the pigs
showed a clear FaeG-specific IgG, IgA or IgM response
in their GALT (data not shown).
3.2. Experiment 2: Cellular responses following
DNA vaccination
3.2.1. Cytokine expression profiles in the local
draining lymph node
To assay cytokine mRNA expression profiles
following DNA vaccination, induction of IL-1a, IL-6,
TNF-a (pro-inflammatory cytokines), IL-2, IFN-g
(Th1-like cytokines), IL-4, IL-10 (Th2-like cytokines)
and TGF-b (Th3-like cytokine) mRNA expression was
evaluated 24 and 48 h psi (Fig. 6, Table 2).
At 24 h psi, a proinflammatory cytokine mRNA
expression could already be observed after injection of
the empty pWRG7079 vector for TNF-a, IL-1 and IL-6
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Fig. 3. FaeG-specific IgM, IgA and IgG ASC/5  106 MC in the Cerv LN 6 or 7 days (day 48 or 49 ppi) after the third i.d. DNAvaccination or the
oral F4 boost. Pigs were immunized as shown in Table 1.(1.6-, 3.2- and 9.4-fold, respectively) and to a lesser
extend after PBS injection for IL-1 and IL-6 (1.5-and
6.7-fold increase, respectively). Only the IL-6 mRNA
expression was increased more strongly by the FaeG
expression (pWRGFaeGopt group, 18.3-fold). A simi-
lar increase in IL-6 mRNA expression could also be
observed in the pWRGFaeGopt + vitD3 group (14.5-
fold), but not in the pWRGFaeGopt + LT group, as the
mean increase in IL-6 mRNA expression in this group
(3.7-fold) was even lower than in the control groups. At48 h psi, the IL-6 mRNA expression was already
strongly decreased, whereas the IL-1 mRNA expression
was increased in the vitD3 group. TNF-a mRNA
expression remained similar in most groups.
For IL-10, IFN-g and TGF-b mRNA, effects were
most pronounced 48 h psi. Expression of TGF-bmRNA
expression was increased following FaeG DNAvaccina-
tion and addition of LTand vitD3 enhanced this increase.
A strong increase in IL-10 mRNA expression could
be observed for one pig of the pWRG7079, the
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Fig. 4. FaeG-specific IgM, IgG and IgA ASC/5  106 MC in the spleen 6 or 7 days (day 48 or 49 ppi) after the third i.d. DNAvaccination or the oral
F4 boost. Pigs were immunized as shown in Table 1.pWRGFaeGopt and the pWRGFaeGopt + vitD3 group,
whereas none of the pigs from the LTadjuvanted groups
showed this increase. For IFN-g, a strong increase in
mRNA expression could only be observed for one pig of
each adjuvanted group.
IL-2 and IL-4 mRNA were hardly detected and are
therefore not shown.
3.2.2. FaeG-specific lymphocyte proliferation
To analyze cellular (memory) immune responses
following i.d. DNA vaccination, MC isolated fromthe Cerv LN 48 h psi or from the spleen 6 or 7
days after the third immunization (pigs from
experiment 1) were restimulated in vitro with F4
(Fig. 7).
At 48 h psi, a strong FaeG-specific proliferation
could only be observed in MC from the Cerv LN of 3 on
4 pWRGFaeGopt + LT (cpm between 36,921 and
134,394) and 1 on 3 pWRGFaeGopt + vitD3 vaccinated
pigs (73,606 cpm). Interestingly, for each pig that
showed a strong increase in IL-10 mRNA expression,
the FaeG-specific proliferation was decreased more
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Fig. 5. FaeG-specific IgG, IgA or IgMASC/5  106MC in the LP, IPP, JPP andMLN 6 or 7 days (day 48 or 49 ppi) after the oral F4 boost. Pigs were
primed by 2 i.d. DNA immunizations as shown in Table 1.than 1.7-fold compared to spontaneous medium
proliferation (data not shown).
Also for spleen cells isolated after three DNA
immunizations, FaeG-specific lymphocyte proliferationwas best induced in the pWRGFaeGopt + LT
group. Indeed, a clear FaeG-specific proliferation
(cpm > 5000) could be observed for 3 on 4 pigs of
this group (cpm between 8420 and 23,167), compared
V. Melkebeek et al. / Veterinary Immunology and Immunopathology 116 (2007) 199–214210
Fig. 6. Cytokine mRNA expression (TNF-a, IL-6, IL-1, TGF-b, IL-10 and IFN-g) at 24 and 48 h psi. Pigs are immunized as shown in Table 2.
Increases in cytokine mRNA expression by i.d. DNA vaccination are given as a ratio = (copy number of target cytokine in the Cerv LN/NF in the
Cerv LN)/(copy number of target cytokine in the control Cerv LN/NF in the control Cerv LN).to 1 on 4 pigs of the pWRGFaeGopt and 1 on 2 pigs of
the pWRGFaeGopt + vitD3 group (cpm of 7758 and
8254, respectively). Moreover, in both the Cerv LN
after 2 DNA immunizations and the spleen after 3 i.d.
DNA vaccinations, the mean cpm value was signifi-
cantly higher in the pWRGFaeGopt + LT group than in
the pWRGFaeGopt group. After the oral F4 boost, a
clear FaeG-specific proliferation was only seen in 1 on 3
pigs of the pWRGFaeGopt + LT group (18,483 cpm).
Spontaneous proliferation was 2260  431 for the
Cerv LN and 1888  213 for the spleen.Fig. 7. FaeG-specific proliferation of Cerv LNMC at 48 h psi and spleen MC
immunized as shown in Tables 1 and 2, respectively. Significant difference4. Discussion
In a first experiment, a heterologous i.d. pWRGFae-
Gopt DNA prime (2)-oral F4 protein boost immuni-
zation and a homologous i.d. pWRGFaeGopt DNA
vaccination (3) were compared for their capacity to
induce systemic and mucosal responses in pigs.
Although i.d. DNA vaccination efficiently induced a
serum IgG response, a clear FaeG-specific serum IgA or
IgM response could not be observed in the present
study. This was in contrast to our previous data where a6 or 7 days (day 48 or 49 ppi) after the third immunization. Pigs were
s are mentioned in the text.
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observed after i.d. pWRGFaeGopt immunization, but
not when the LT vectors were added (Melkebeek et al.,
2007). These contradicting findings might result from
differences in origin of the pigs. Indeed, individual
variation in immune responses, including Ig isotype
responses, has been described for outbred pigs and has
been attributed to differences in genetic background and
environmental factors (Crawley et al., 2003, Wilkie and
Mallard, 1999). A second reason could be an unnoticed
minor contact with F4. Indeed, it has been described
that intestinal priming can result in an IgA response
following parenteral immunization (Svennerholm et al.,
1980). Although farms were carefully selected for
absence of F4+ ETEC related problems, litters were
tested to be F4-seronegative and pigs were orally treated
with colistine to prevent infection during the weaning
period, a risk for such a contact can not absolutely be
excluded.
Our inability to demonstrate a serum IgM reponse is
likely due to the high cut off value in the IgM ELISA.
An IgM background is often observed when young
animals are tested. This is likely non-specific as even for
gnotobiotic piglets, cut off values near 0.4 could be
observed in F4-specific serum IgM ELISA (recent
unpublished data from our lab). Furthermore, also in
lymphoid tissues, a background of IgM ASC is often
observed (Van den Broeck et al., 1999b; Verdonck et al.,
2002; Snoeck et al., 2006a), even for F4R pigs which
are resistant to F4+ ETEC infection.
After both the third i.d. DNA immunization and the
oral F4 boost, antibody responses were mainly located
systemically. After the i.d. DNA boost, responses in the
adjuvanted groups were not better than those in the
pWRGFaeGopt group, suggesting that other tissues,
such as the bone marrow, might account for the higher
serum IgG titer in these groups. Indeed, a study by
Bianchi et al. (1999) demonstrated that the bone marrow
is the major site of IgG production in pigs, containing
40% of all IgG secreting cells.
The presence of low numbers of IgAASC in the Cerv
LN following three intradermal DNA vaccinations is in
line with our previous data indicating that i.d. DNA
vaccination preceded by GM-CSF DNA injection
primes a serum IgA response that can be boosted
systemically (Melkebeek et al., 2006) but not mucosally
(Melkebeek et al., 2007). An IgA response following
systemic immunization was also seen in earlier studies
in pigs (Van der Stede et al., 2002) and was more
efficiently induced by immunizing in the neck
compared to the back. The dorsal superficial cervical
LN draining the neck region is connected to lymphnodes draining mucosal sites (mandibular and medial
retropharyngeal LN draining tonsils and nasal mucosa),
which might be more beneficial for the induction of IgA
(Vanderpooten et al., 1997).
Compared to the i.d. DNA boost, the oral F4 boost
was clearly more immunogenic for the adjuvanted
groups, as judged by an enhanced isotype switching
towards IgG in the spleen and increased numbers of IgG
ASC in the Cerv LN. This is in agreement with other
studies demonstrating that prime-boost immunizations
by alternating routes and/or immunization forms are as
immunogenic or more immunogenic than homologous
prime-boost immunizations (Baca-Estrada et al., 2000;
McCluskie et al., 2002; Lauterslager et al., 2003). As
observed previously (Melkebeek et al., 2007), boosting
of systemic responses in parenterally primed pigs by
oral F4 administration appeared to be independent of
the F4R status of the pigs.
Besides inducing a systemic response, parenteral
immunization, for example with live attenuated patho-
gens (Coffin et al., 1995) or in the presence of
immunomodulating adjuvants like vitD3, enterotoxins
or chemical enhancers of cAMP (Enioutina et al., 1999,
2000; Van der Stede et al., 2004) has also been
demonstrated to induce IgA ASC in the GALT. In our
study however, an intestinal mucosal antibody response
was nearly undetectable following i.d. DNA immuniza-
tion. After the oral boost, the intestinal FaeG-specific
IgA and IgM response were variable and an improve-
ment by DNA priming could only be observed for a few
pigs. In line with our previous results (Melkebeek et al.,
2007), IgG ASC could be detected in the Mes LN of the
DNA primed and especially of the adjuvanted groups.
Moreover, although the presence of the F4R is required
to induce IgA and IgM ASC in the Mes LN and other
GALT of naı¨ve pigs following multiple oral F4
administrations (Van den Broeck et al., 1999a),
intestinal responses in DNA primed-orally boosted
pigs were independent of the F4R status, suggesting an
increased responsiveness of the parenterally primed
animals to oral immunization. In contrast to other
studies in mice and pigs demonstrating that vitD3
enhances IgG but also IgA responses in the inductive
sites of the GALT following parenteral immunization
(Enioutina et al., 1999, 2000; Van der Stede et al.,
2004), addition of vitD3 to the FaeG DNAvaccine failed
to prime for the intestinal mucosal IgA response that is
desired to protect piglets against an F4+ ETEC
infection.
In a second experiment, we evaluated the induction
of cellular responses following i.d. DNAvaccination. A
clear FaeG-specific lymphocyte proliferation could
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vectors. A strong positive influence of these vectors on
the antigen-specific cellular response has previously
been described (Arrington et al., 2002;Melkebeek et al.,
2007). This might result from a higher phenotypic and
functional maturation of APC (Bagley et al., 2002;
Martin et al., 2002), resulting in a better antigen-
presentation in the presence of LT and thus in a higher
number of FaeG-specific memory lymphocytes and/or
from a different subset of T(h)-cells and/or cytokine-
profile after immunization. For the latter, evidence was
obtained by analyzing cytokine mRNA profiles in the
Cerv LN.
Pro-inflammatory cytokines were already weakly
induced by the injection on itself (PBS group) and even
slightly more by the DNA vector, with only the IL-6
mRNA expression being further up regulated by the
FaeG expression. FaeG expression also resulted in an
increased TGF-b mRNA expression, especially when
an adjuvant was added. TGF-b has been suggested to be
involved in the mucosal homing of immunocompetent
cells (Enioutina et al., 1999) and is known to play a role
in the isotype switching towards IgA (Lebman et al.,
1990; Iwasato et al., 1994). For the expression of IL-10
(Th2-like) and IFN-g (Th1-like) mRNA, a high
variability could be observed among the animals.
Furthermore, in line with other studies in pigs
(Suradhat et al., 2003; Reddy et al., 2000), expression
of IL-4 (Th2-like) and IL-2, could not be detected. It
has been speculated that in pigs other molecules may
substitute functionally for classical murine cytokines,
like IL-4 and perhaps IL-2 (Reddy et al., 2000). IL-4
function might be substituted by IL-13 (Reddy et al.,
2000), which has not been measured here. Conse-
quently, we were not able to attribute a typical Th-
cytokine profile to FaeG DNA vaccination and/or the
LT vectors and vitamin D3. What we did observe was a
suppression of the FaeG-specific lymphocyte prolif-
eration with increased IL-10 mRNA levels. This is in
line with studies in man and cattle demonstrating that
IL-10 inhibits Th1- and Th2-cell proliferation in these
species (Del Prete et al., 1993; Brown et al., 1994).
Moreover, although IL-10 mRNA expression was
highly variable, the absence of a clear IL-10 response
in the LT group might at least have contributed to the
strong FaeG-specific proliferation observed in the
presence of the LT vectors. Furthermore, IL-10
synergizes with TGF-b to increase the efficiency of
IgA switching (Defrance et al., 1992), while IL-6,
together with IL-5 acts to enhance the IgA secretion
(Snoeck et al., 2006b). So, although no serum IgA
response could be observed in the present study (asdiscussed above), suppression of both IL-6 and IL-10
mRNA expression by the LT vectors might explain the
suppressed serum IgA response in our previous study
(Melkebeek et al., 2007).
In conclusion, even after the oral F4 boost, priming
of an intestinal mucosal antibody response remained
weak, varied among the pigs and seemed to require co-
administration of the LT vectors or vitD3. Moreover,
even in presence of these adjuvants, we failed to
demonstrate the secretory IgA response that is needed to
be protective against ETEC. Therefore, further research
should be directed towards enhancing the IgA response
following DNA vaccination.
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